Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Sjögren, Magnus
Minthon, Lennart
Passant, Ulla
Blennow, Kaj
and
Wallin, Anders
1998.
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s disease.
Neurobiology of Aging,
Vol. 19,
Issue. 5,
p.
379.
Wallin, A
Jennersjö, C
and
Granérus, A.-K
1999.
Prevalence of dementia and regional brain syndromes in long-standing Parkinson's disease.
Parkinsonism & Related Disorders,
Vol. 5,
Issue. 3,
p.
103.
Tarkowski, E.
Wallin, A.
Regland, B.
Blennow, K.
and
Tarkowski, A.
2001.
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia.
Acta Neurologica Scandinavica,
Vol. 103,
Issue. 3,
p.
166.
Linnér, Erik
Popovic, Vladislav
Gottfries, Carl‐Gerhard
Jonsson, Michael
Sjögren, Magnus
and
Wallin, Anders
2001.
The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer’s type.
Acta Ophthalmologica Scandinavica,
Vol. 79,
Issue. 3,
p.
283.
Tarkowski, Elisabeth
Issa, Razao
Sjögren, Magnus
Wallin, Anders
Blennow, Kaj
Tarkowski, Andrej
and
Kumar, Pat
2002.
Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia.
Neurobiology of Aging,
Vol. 23,
Issue. 2,
p.
237.
Bogousslavsky, Julien
and
Ghika, J
2002.
Long-Term Effects of Stroke.
Dhondt, Jean-Louis
2004.
Difficulties in establishing reference intervals for special fluids: the example of 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluids.
Clinical Chemistry and Laboratory Medicine (CCLM),
Vol. 42,
Issue. 7,
Stiasny‐Kolster, Karin
Möller, J. Carsten
Zschocke, Johannes
Bandmann, Oliver
Cassel, Werner
Oertel, Wolfgang H.
and
Hoffmann, Georg F.
2004.
Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients.
Movement Disorders,
Vol. 19,
Issue. 2,
p.
192.
García‐Cazorla, A
Serrano, M
Pérez‐Dueñas, B
González, V
Ormazábal, A
Pineda, M
Fernández‐álvarez, E
Campistol, J M D
and
Artuch, R M D
2007.
Secondary abnormalities of neurotransmitters in infants with neurological disorders.
Developmental Medicine & Child Neurology,
Vol. 49,
Issue. 10,
p.
740.
Herbert, Megan K.
Aerts, Marjolein B.
Kuiperij, H. Bea
Claassen, Jurgen A.H.R.
Spies, Petra E.
Esselink, Rianne A.J.
Bloem, Bastiaan R.
and
Verbeek, Marcel M.
2014.
Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.
Alzheimer's & Dementia,
Vol. 10,
Issue. 4,
p.
448.
Watne, Leiv Otto
Idland, Ane-Victoria
Fekkes, Durk
Raeder, Johan
Frihagen, Frede
Ranhoff, Anette Hylen
Chaudhry, Farrukh Abbas
Engedal, Knut
Wyller, Torgeir Bruun
and
Hassel, Bjørnar
2016.
Increased CSF levels of aromatic amino acids in hip fracture patients with delirium suggests higher monoaminergic activity.
BMC Geriatrics,
Vol. 16,
Issue. 1,
Wallin, Anders
Nordlund, Arto
Jonsson, Michael
Blennow, Kaj
Zetterberg, Henrik
Öhrfelt, Annika
Stålhammar, Jacob
Eckerström, Marie
Carlsson, Mårten
Olsson, Erik
Göthlin, Mattias
Svensson, Johan
Rolstad, Sindre
Eckerström, Carl
and
Bjerke, Maria
2016.
Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.
Journal of Cerebral Blood Flow & Metabolism,
Vol. 36,
Issue. 1,
p.
95.